The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease
Abstract Obese and overweight children are at risk of developing nonalcoholic fatty liver disease (NAFLD), which can lead to steatohepatitis, cirrhosis, and liver transplantation. Neuropsychiatric conditions affect an increasing proportion of children and often require neuropsychiatric medications (...
Saved in:
Main Authors: | Jamie L. Ryan (Author), Ashley K. Sherman (Author), Daniel E. Heble (Author), Craig A. Friesen (Author), James F. Daniel (Author), Ryan T. Fischer (Author), Voytek Slowik (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease
by: Voytek Slowik, et al.
Published: (2021) -
Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
by: Hye Ran Yang
Published: (2013) -
Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
by: Eun Jeong Kim, et al.
Published: (2019) -
Nonalcoholic Fatty Liver Disease An Update
Published: (2019) -
Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023)